4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-20-000298
EVP Strategy and Corporate Dev sold 1,079 shares at an average $403.18 ($435,030)
From the SEC's structured data for this filing
Trades in this filing
Pacelli Steven Robert · EVP Strategy and Corporate Dev
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-23 | Sale : show line 1 in the form | −239 | $397.49 | $95,000 | 62,779 | D |
| 2020-10-23 | Sale : show line 2 in the form | −149 | $399.62 | $59,543 | 62,630 | D |
| 2020-10-23 | Sale : show line 3 in the form | −70 | $402.61 | $28,183 | 62,560 | D |
| 2020-10-23 | Sale : show line 4 in the form | −170 | $404.91 | $68,834 | 62,390 | D |
| 2020-10-23 | Sale : show line 5 in the form | −173 | $405.99 | $70,237 | 62,217 | D |
| 2020-10-23 | Sale : show line 6 in the form | −195 | $407.02 | $79,369 | 62,022 | D |
| 2020-10-23 | Sale : show line 7 in the form | −83 | $408.00 | $33,864 | 61,939 | D |
| Open-market sales · 1,079 sh · avg $403.18 · $435,030 | ||||||
Loading xslF345X03/edgardoc.xml…